Major U.S. indices closed higher on Wednesday, with the Dow Jones Industrial Average rising 0.22% to 53,463.05, the S&P 500 gaining 0.21% to 7,707.98 and the Nasdaq advancing 0.16% to 26,331.09.
These are the top stocks that gained the attention of retail traders and investors through the day:
Moderna Inc. (NASDAQ:MRNA)
Moderna’s stock skyrocketed by 176.97%, closing at $174.38. The stock hit an intraday high of $176.66 and a low of $114.46, marking a new 52-week high. In the after-hours session, the stock fell 4.65% to $166.26.
Moderna shares surged after its personalized mRNA cancer vaccine with Merck succeeded in a Phase 3 melanoma trial, marking the first Phase 3 win for an mRNA-based cancer treatment. The result could shift investor perception of Moderna from a post-pandemic vaccine maker toward a potential oncology platform.
